8 funds hold both · as on Jul 2026
Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 8 mutual funds hold active equity positions in both Ajanta Pharma and Marksans Pharma. The scheme with the highest combined exposure is UTI - Healthcare Fund (UTI MF), which holds a 4.80% stake in Ajanta Pharma and a 2.17% stake in Marksans Pharma, amounting to a combined conviction weight of 6.97%.
When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.
| Fund | Ajanta wt. | Marksans wt. | Combined |
|---|---|---|---|
| UTI - Healthcare FundUTI MF · Sectoral / Thematic | 4.80% | 2.17% | |
| Kotak Healthcare FundKotak MF · Sectoral / Thematic | 2.29% | 2.27% | |
| UTI Large & Mid Cap FundUTI MF · Large & Mid Cap | 1.29% | 0.80% | |
| UTI Multi Cap FundUTI MF · Multi Cap | 1.20% | 0.84% | |
| Back to IndexMotilal Oswal MF · Index Fund | 0.91% | 0.34% | |
| UTI Aggressive Hybrid FundUTI MF · Hybrid | 0.68% | 0.55% | |
| UTI Retirement FundUTI MF · Solution-Oriented | 0.54% | 0.26% | |
| IB18-Groww Nifty Total Market Index FundGroww MF · Index Fund | 0.05% | 0.02% |
These funds hold both stocks — see how much their entire portfolios overlap.
Check overlap of top funds →“Holds both” = the fund discloses an equity position in each stock in its latest public monthly portfolio (as on Jul 2026). Weight = the position as a % of that fund's portfolio. ISIN-verified from AMC disclosures. Not investment advice.